Vitality Watch

Dossier pubmed observational 22-sep-2026
Human cohort, case-control, or epidemiological association

Clinical obesity phenotypes among older adults: prevalence, determinants, and morbidity burden from the Longitudinal Ageing Study in India.

Key claim: In LASI Wave 1, 37.5% of Indian adults ≥45 had preclinical (15.0%) or clinical (22.5%) obesity under the 2025 Lancet framework, with higher odds in women, urban and wealthier groups, and the socially isolated, and clear excess cardiometabolic and multimorbidity burden versus non-obesity.

Abstract

BACKGROUND: Routine obesity diagnosis in India largely relies on BMI, often failing to capture metabolic heterogeneity in older adults. This study is the first to operationalize the 2025 Lancet consensus framework at a national scale, distinguishing between excess adiposity (pre-clinical) and adiposity with comorbidities (clinical obesity). METHODS: We analyzed data from 60640 adults aged ≥45 years from the Longitudinal Ageing Study in India (LASI, Wave 1). Using Asian-specific BMI and waist circumference thresholds integrated with physician-diagnosed conditions, participants were classified as without obesity, preclinical obesity, or clinical obesity. Multivariable regression models examined sociodemographic, behavioral, and psychosocial determinants. RESULTS: Overall, 37.53% of older adults had either preclinical or clinical obesity, comprising 15.00% with preclinical obesity (95% CI: 14.27-15.75) and 22.53% with clinical obesity (95% CI: 21.71-23.37). Non-obesity accounted for 62.47% (95% CI: 61.55-63.39). In the fully adjusted model, higher odds of increasing obesity category were observed among women (AOR = 1.97), urban residents (AOR = 1.88), individuals in the richest MPCE quintile (AOR = 1.91), and socially isolated individuals (AOR = 1.44). Adults aged ≥70 years had lower odds (AOR = 0.80). Compared with individuals without obesity, those with preclinical or clinical obesity had higher prevalence of hypertension, diabetes, chronic heart disease, chronic bone or joint disease, high cholesterol, and multimorbidity. CONCLUSION: A substantial proportion of older adults in India had preclinical or clinical obesity, particularly women, urban residents, socioeconomically advantaged groups, and socially isolated individuals. Phenotype-based classification adds value beyond BMI by distinguishing excess adiposity without morbidity from adiposity with clinical manifestations, supporting refined population-level risk stratification. Public health strategies should strengthen early identification, integrate waist circumference and morbidity assessment into older-adult NCD screening, and address social and structural factors associated with obesity burden.

Why this matters

The 2025 Lancet framework splits obesity into ‘preclinical’ (adiposity without organ dysfunction) and ‘clinical’ (adiposity with attributable morbidity), and this is the first population-scale attempt to apply it — showing that in older Indian adults more than a third already meet one of the two categories, with clinical obesity carrying a distinct cardiometabolic and multimorbidity signature. For the nutrition-and-aging area, it reframes ‘obesity prevalence’ as two epidemiologically separable states rather than a single BMI bucket, and highlights that the burden concentrates in socially and demographically specific subgroups rather than uniformly across the aging population.

Source

Link

Briefing card

Clinical obesity phenotypes among older adults: prevalence, determinants, and morbidity burden from the Longitudinal Ageing Study in India.
Stage: observational · pubmed · 22-sep-2026

If you are an Indian adult over 45, roughly 1 in 5 in your peer group would now be classified as having clinical obesity under the 2025 Lancet definition, with measurably higher cardiometabolic and multimorbidity burden than non-obese peers.

In LASI Wave 1, 37.5% of Indian adults ≥45 had preclinical (15.0%) or clinical (22.5%) obesity under the 2025 Lancet framework, with higher odds in women, urban and wealthier groups, and the socially isolated, and clear excess cardiometabolic and multimorbidity burden versus non-obesity.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1038/s41366-026-02226-9

build build 880 · 2bcef25 · 2026-11-18